Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0P1CD
|
||||
Former ID |
DIB018436
|
||||
Drug Name |
[3H]YM298198
|
||||
Synonyms |
[3H]-YM298198
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [540801] | ||
Formula |
C18H22N4OS
|
||||
InChI |
InChI=1S/C18H22N4OS/c1-11-16(17(23)21(2)13-6-4-3-5-7-13)24-18-20-14-9-8-12(19)10-15(14)22(11)18/h8-10,13H,3-7,19H2,1-2H3
|
||||
InChIKey |
KCBXOMYXOBVLED-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Metabotropicglutamate receptor 1 | Target Info | Modulator (allosteric modulator) | [527604] | |
References | |||||
Ref 527604 | Radioligand binding properties and pharmacological characterization of 6-amino-N-cyclohexyl-N,3-dimethylthiazolo[3,2-a]benzimidazole-2-carboxamide (YM-298198), a high-affinity, selective, and noncompetitive antagonist of metabotropic glutamate receptor type 1. J Pharmacol Exp Ther. 2005 Oct;315(1):163-9. Epub 2005 Jun 23. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.